伽玛刀放射外科治疗大脑镰与小脑幕汇合处脑膜瘤
该回顾性研究纳入1987至2021年间在本机构接受伽玛刀放射外科治疗的20例大脑镰与小脑幕汇合处脑膜瘤患者,中位肿瘤边缘剂量13 Gy(50%等剂量线),中位肿瘤体积4.4 cc,中位MRI随访59个月,5年和10年局部肿瘤控制率分别为100%和83%,5年和10年总生存率均为100%,随访期间无患者出现放射性不良反应。
要点
- 5年和10年局部肿瘤控制率分别为100%(N=10)和83%(N=4)。
- 5年和10年总生存率均为100%(N=13和N=7)。
- 随访期间无患者出现放射性不良反应。
核心结论
- 伽玛刀放射外科是新诊断的大脑镰与小脑幕汇合处脑膜瘤或手术切除后进展性残余肿瘤患者的有价值治疗策略。
研究设计与样本
- 回顾性识别1987年至2021年间在本机构接受伽玛刀放射外科治疗的2031例脑膜瘤患者中的20例大脑镰与小脑幕汇合处脑膜瘤。
- 中位肿瘤边缘剂量为13 Gy(50%等剂量线),中位治疗肿瘤体积为4.4 cc(IQR 3.5-7.7)。
- 中位患者年龄58岁(范围33-83),中位MRI监测持续时间59个月(IQR 34-92),中位总随访持续时间92个月(IQR 42-201)。
主要发现
- 5年和10年局部肿瘤控制率(无进展生存)分别为100%(N=10)和83%(N=4)。
- 8例患者肿瘤体积稳定,11例患者肿瘤消退。
- 1例曾两次手术的患者在7.5年时出现延迟进展,并再次接受伽玛刀放射外科治疗。
- MRI监测期间无患者出现放射性不良反应。
- 5年和10年总生存率分别为100%(N=13)和100%(N=7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningiomas arising from the confluence of the falx and tentorium (CFT) are a rare and challenging subset of meningiomas. Gamma Knife radiosurgery (GKRS) is well-established as a safe and effective management strategy for intracranial meningiomas, but its role in treating CFT meningiomas is not well-described. This paper reports the largest series focused exclusively on the outcomes of GKRS for CFT meningiomas. METHODS: We retrospectively identified 20 CFT meningiomas out of 2031 meningioma patients who underwent GKRS at our institution between 1987 and 2021. Tumor control, overall survival (OS), and complications were recorded and analyzed. The median tumor margin dose was 13 Gy at the 50% isodose line. The median tumor volume treated was 4.4 cc (IQR 3.5-7.7). The median patient age was 58 years (range 33-83), the median MRI surveillance duration was 59 months (IQR 34-92), and the median overall follow-up duration was 92 months (IQR 42-201). RESULTS: The local tumor control rate (PFS) at 5 and 10-years were 100% (N=10) and 83% (N=4), respectively. Eight patients had stable tumor volumes and 11 patients had regression. One patient with a twice-operated tumor had delayed progression at 7.5 years and was retreated with GKRS. No patient had adverse radiation effects during the period of MRI surveillance. The 5 and 10-year OS were 100% (N=13) and 100% (N=7), respectively. CONCLUSIONS: GKRS is a valuable therapeutic strategy for patients with newly diagnosed CFT meningiomas or progressive residual tumors after surgical resection.
引用
- Abdallah HM, Mallela AN, Wei Z, et al. Gamma Knife radiosurgery for meningiomas of the confluence of the falx and tentorium. J Neurooncol. 2022. PMID: 36125641. doi:10.1007/s11060-022-04125-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。